January 16, 2021

The Niche

Trusted stem cell blog & resources

NeoStem

2 min read

To get from point A of a stem cell discovery to point B of a patient actually receiving a treatment based on that discovery is a long and non-linear road, which requires biotech company research. Stem cell biotech companies including publicly traded companies are an integral part of the field making that journey. How those companies fare financially is not just of interest to investors, but also should be on the radar screen of scientists and advocates too. Lately, stem cell companies have not …Read More

4 min read

Each year towards the end of December I make predictions for the coming year as I did for 2015. In the past I usually make a top 10 prediction list, but for this year I made 20 predictions. Admittedly some of them may have been more hopes than predictions. At mid-year today on June 30th, how am I doing with 2015 predictions? See below. Note that of course for some the jury is still out. BTW, stay tuned for more on an upcoming update …Read More

1 min read

CIRM has reinvented itself in a new form, CIRM 2.0, under the leadership of its new President Randy Mills. CIRM is almost like a stem cell that has changed into another new kind of stem cell. Us scientists could see the change coming in the “programming” at CIRM in terms of how it was operating as the 2.0 version, but what would it bring in practical terms? We are starting to see the new CIRM 2.0 in action and by all signs it looks pretty …Read More

2 min read

What are the most interesting questions for the stem cell field in 2014 right now? What’s on your mind? I’m not going to give this deep thought, but rather just list those questions bouncing around at the moment in no particular order. You can see a lot of translational/clinical things are on my mind. I’ve put possible answers, but these are highly speculative and/or based on hope in some cases. What’s next for ACT’s hESC-based clinical trials and Takahashi’s iPS cell-based clinical study for macular …Read More

1 min read

Late last year I was hearing some exciting things about California Stem Cell, Inc. under the leadership of Hans Keirstead. (2020 update: interestingly 3 years ago Keirstead ran for congress, but the campaign didn’t quite make it.) In fact, I thought a big move for California Stem was in the cards for 2014 and looking into my stem cell crystal ball, I went so far as to make that one of my top 10 stem cell predictions for 2014. Today, that prediction came true with …Read More

1 min read

I’ve added a fun and helpful new feature on the right side bar of the blog in the form of a stem cell biotech stock ticker. The ticker is for some of the most widely held stem and cellular medicine companies. A sample screen shot is shown in this post. Quite a few stem cell-related stocks could not be added to this ticker for various reasons including ACTC, Mesoblast, CUR, and others. Yahoo has limits on which stocks can be included based on company …Read More

4 min read

One of the more controversial areas in the stem cell field has been over a Sasquatch like stem cell type that only a handful of researchers have been able to find and study: very small embryonic-like stem cells (VSELs). A Sasquatch is a generally thought to be mythological creature from the Pacific Northwest area of the US where I grew up, also sometimes called Big Foot. Some folks believe in the Sasquatch. Some people believe in VSELs too.  I’m more interested in what you think …Read More

4 min read

Are MUSE cells for real? Stem cells come in different types that vary in a key property called “potency”, but very few are pluripotent. The more potency, the greater the flexibility of a stem cell to make other cell types. Flexibility in the cellular world is power. The most powerful stem cells generally used are called “pluripotent”, which refers to a special kind of stem cell that can make all 200+ other types of cells in the body through differentiation. Pluripotent stem cells are hard …Read More

1 min read

The Catholic Church has long opposed embryonic stem cell research even as it has shown signs of getting more interested in adult stem cell research. I am an advocate of both types of research and both go on in my own lab. Now that we will have a new Pope this year, I wonder how this new leader of the Catholic Church might impact stem cell research? Naively, one might say that the new Pope could be less polarizing on stem cell research, but …Read More